Hepatitis C Treatments are Too Expensive for Most Americans; CBCD Reviews the Evidence

[et_pb_section admin_label=”section” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off”][et_pb_row admin_label=”row”][et_pb_column type=”4_4″][et_pb_text admin_label=”Blog Text Content” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]

Dr. Searson wrote that while new and effective drugs are entering the market, “it is too soon to declare victory. It has even been said that we are only ‘at the end of the beginning’ of the struggle.”

Click Here to Read More on PR Underground…

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]